BOEING CO/THE (BA)
US0970231058 - Common Stock
Overall BA gets a fundamental rating of 1 out of 10. We evaluated BA against 65 industry peers in the Aerospace & Defense industry. Both the profitability and financial health of BA have multiple concerns. BA is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BA had negative earnings in the past year.
BA had a negative operating cash flow in the past year.
In the past 5 years BA always reported negative net income.
In multiple years BA reported negative operating cash flow during the last 5 years.
1.2 Ratios
BA's Return On Assets of -5.79% is on the low side compared to the rest of the industry. BA is outperformed by 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.79% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-2.75%
ROA(5y)-3.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 3.13%, BA is doing worse than 83.08% of the companies in the same industry.
In the last couple of years the Gross Margin of BA has declined.
The Profit Margin and Operating Margin are not available for BA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 3.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.55%
2. Health
2.1 Basic Checks
BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BA has been increased compared to 1 year ago.
BA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BA has been reduced compared to a year ago.
2.2 Solvency
BA has an Altman-Z score of 1.08. This is a bad value and indicates that BA is not financially healthy and even has some risk of bankruptcy.
BA has a Altman-Z score of 1.08. This is in the lower half of the industry: BA underperforms 73.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.08 |
ROIC/WACCN/A
WACC8.26%
2.3 Liquidity
BA has a Current Ratio of 1.12. This is a normal value and indicates that BA is financially healthy and should not expect problems in meeting its short term obligations.
BA's Current ratio of 1.12 is on the low side compared to the rest of the industry. BA is outperformed by 73.85% of its industry peers.
A Quick Ratio of 0.27 indicates that BA may have some problems paying its short term obligations.
The Quick ratio of BA (0.27) is worse than 95.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.27 |
3. Growth
3.1 Past
BA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -110.42%.
Looking at the last year, BA shows a decrease in Revenue. The Revenue has decreased by -3.25% in the last year.
Measured over the past years, BA shows a decrease in Revenue. The Revenue has been decreasing by -5.11% on average per year.
EPS 1Y (TTM)-110.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-220.25%
Revenue 1Y (TTM)-3.25%
Revenue growth 3Y9.87%
Revenue growth 5Y-5.11%
Sales Q2Q%-1.46%
3.2 Future
The Earnings Per Share is expected to grow by 36.21% on average over the next years. This is a very strong growth
Based on estimates for the next years, BA will show a quite strong growth in Revenue. The Revenue will grow by 10.31% on average per year.
EPS Next Y-183.48%
EPS Next 2Y44.53%
EPS Next 3Y41.71%
EPS Next 5Y36.21%
Revenue Next Year-10.51%
Revenue Next 2Y6.08%
Revenue Next 3Y8.79%
Revenue Next 5Y10.31%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
BA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 278.31, BA can be considered very expensive at the moment.
BA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BA is more expensive than 64.62% of the companies in the same industry.
BA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.56.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 278.31 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as BA's earnings are expected to grow with 41.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.53%
EPS Next 3Y41.71%
5. Dividend
5.1 Amount
BA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BOEING CO/THE
NYSE:BA (11/21/2024, 3:20:02 PM)
143.85
-2.23 (-1.53%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap107.48B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 278.31 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.79% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 3.13% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.27 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-110.42%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-183.48%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.25%
Revenue growth 3Y9.87%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y